
Bactiguard Holding
33
SEK
+1,23 %
Mindre end 1K følgere
BACTI B
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
+1,23%
+11,86%
-2,94%
-6,52%
-22,35%
-52,03%
-71,3%
-77,24%
+4,76%
Bactiguard is a global MedTech company that prevent infections related to medical devices. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation. Bactiguard operates through license partnerships with MedTech companies that apply the technology to their medical devices. The company also has a portfolio of wound management products. Bactiguard has its headquarters in Stockholm.
Læs mereMarkedsværdi
1,16 mia. SEK
Aktieomsætning
16,24 t SEK
Omsætning
241,68 mio.
EBIT %
-11,94 %
P/E
-
Udbytteafkast, %
-
Finanskalender
15.5
2025
Generalforsamling '25
15.7
2025
Delårsrapport Q2'25
23.10
2025
Delårsrapport Q3'25
Alle
Selskabspræsentationer
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper

Carnegie Access: Bactiguard: Slightly higher sales in Q1 than we expected
Bactiguard Holding AB (publ): Bactiguard Holding AB's interim report first quarter 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Bactiguard Holding AB (publ): Bactiguard Holding AB's Annual and Sustainability Report 2024
Bactiguard Holding AB (publ): Invitation to presentation of Bactiguard's interim report for the first quarter 2025
Bactiguard Holding AB (publ): Notice to attend the Annual General Meeting of Bactiguard Holding AB
Bactiguard Holding AB (publ): The Nomination Committee's proposal for Board of Directors to the 2025 Annual General Meeting

Bactiguard Audiocast with teleconference, Updated strategic and financial targets, 2025
Carnegie Access: Bactiguard: New financial targets look more realistic
Bactiguard Holding AB (publ): Bactiguard announces updated strategic and financial targets
Carnegie Access: Bactiguard: Solid Q4, but poor visibility for future growth drivers

Bactiguard, Audiocast with teleconference, Q4'24
Carnegie Access: Bactiguard: Higher sales than expected in Q4, but no news on financial targets
Bactiguard Holding AB (publ): Bactiguard Holding AB's year-end report 2024
Bactiguard Holding AB (publ): Invitation to presentation of Bactiguard's year-end report for 2024
Carnegie Access: Waiting for new long-term targets to be announced – Q4 preview
Carnegie Commissioned Research: Bactiguard: More needed for the share price to lift
Bactiguard Holding AB (publ): Nomination Committee appointed for Bactiguard Holding AB's Annual General Meeting 2025
